MITO END-4
National Cancer Institute, Naples
National Cancer Institute, Naples
Regor Pharmaceuticals Inc.
University of Rochester
Radboud University Medical Center
Centre hospitalier de l'Université de Montréal (CHUM)
Cogent Biosciences, Inc.
Rutgers, The State University of New Jersey
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
Taipei Veterans General Hospital, Taiwan
European Institute of Oncology
Natera, Inc.
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Second Life Therapeutics
Rocky Vista University, LLC
Sun Yat-sen University
Centre Leon Berard
University College, London
Centre Georges Francois Leclerc
GlaxoSmithKline
Peking University People's Hospital
Seoul National University Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Health Network, Toronto
Peking University People's Hospital
University of South Florida
Istanbul University
Universidade Federal de Pernambuco
Akdeniz University
Peking Union Medical College Hospital
AstraZeneca
Peking Union Medical College Hospital
BioMimetix JV, LLC
Danatlas Pharmaceuticals Co., Ltd
Fudan University
Peking University People's Hospital
Sohag University
NovaOnco Therapeutics Co., Ltd.
Peking University People's Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Zhongnan Hospital